AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 86 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $79,891 | -91.2% | 11,158 | -90.1% | 0.00% | -100.0% |
| Q4 2021 | $911,000 | +432.7% | 112,797 | +547.9% | 0.00% | – |
| Q3 2021 | $171,000 | +61.3% | 17,410 | +49.0% | 0.00% | – |
| Q1 2021 | $106,000 | +960.0% | 11,688 | +390.7% | 0.00% | – |
| Q3 2018 | $10,000 | -90.7% | 2,382 | -86.5% | 0.00% | – |
| Q2 2018 | $108,000 | -59.7% | 17,607 | -52.1% | 0.00% | – |
| Q1 2018 | $268,000 | – | 36,751 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 985,210 | $10,345,000 | 6.10% |
| Broadfin Capital, LLC | 3,568,122 | $37,465,000 | 5.54% |
| JW Asset Management, LLC | 444,439 | $4,667,000 | 3.42% |
| ARMISTICE CAPITAL, LLC | 1,688,000 | $17,724,000 | 2.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,655,494 | $38,383,000 | 1.73% |
| FALCON POINT CAPITAL, LLC | 661,490 | $6,284,000 | 0.91% |
| KNOTT DAVID M | 158,555 | $1,665,000 | 0.71% |
| Perceptive Advisors | 3,098,010 | $32,530,000 | 0.62% |
| Sio Capital Management, LLC | 91,413 | $960,000 | 0.50% |
| HEARTLAND ADVISORS INC | 700,000 | $7,350,000 | 0.48% |